Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merve Bilici

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical and Experimental Immunology|August 12, 2022
Regulatory T-cell therapy approachesOliver McCallion, Merve Bilici, Joanna Hester, et al.
Physiological Reports|August 3, 2021
The effect of endurance training on non-alcoholic fatty liver disease in miceLuma Melo, Merve Bilici, Amit Hagar, et al.
Molecular Biology Reports|June 30, 2021
The secretome of mesenchymal stem cells and oxidative stress: challenges and opportunities in cell-free regenerative medicineBahareh Rahimi, Mohammad Panahi, Neda Saraygord-Afshari, et al.
Nature Communications|October 13, 2025
HLA matching or CRISPR editing of HLA class I/II enables engraftment and effective function of allogeneic human regulatory T cell therapy in a humanized mouse transplantation modelOliver McCallion, Weijie Du, Viktor Glaser, et al.
Blood|March 2, 2026
TCR T cells targeting IgA- and IgG-expressing multiple myelomaKarolos Douvlataniotis, Aleksei Titov, Julia Zeun, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Immunology|August 12, 2022
Regulatory T-cell therapy approachesOliver McCallion, Merve Bilici, Joanna Hester, et al.
Physiological Reports|August 3, 2021
The effect of endurance training on non-alcoholic fatty liver disease in miceLuma Melo, Merve Bilici, Amit Hagar, et al.
Molecular Biology Reports|June 30, 2021
The secretome of mesenchymal stem cells and oxidative stress: challenges and opportunities in cell-free regenerative medicineBahareh Rahimi, Mohammad Panahi, Neda Saraygord-Afshari, et al.
Nature Communications|October 13, 2025
HLA matching or CRISPR editing of HLA class I/II enables engraftment and effective function of allogeneic human regulatory T cell therapy in a humanized mouse transplantation modelOliver McCallion, Weijie Du, Viktor Glaser, et al.
Blood|March 2, 2026
TCR T cells targeting IgA- and IgG-expressing multiple myelomaKarolos Douvlataniotis, Aleksei Titov, Julia Zeun, et al.
Pageof 1